InvestorsHub Logo
Followers 6
Posts 355
Boards Moderated 0
Alias Born 12/30/2015

Re: None

Sunday, 07/09/2017 5:19:22 PM

Sunday, July 09, 2017 5:19:22 PM

Post# of 402252
Elite has more things working!
SquestOX may be PAUSED for now but Elite still has-
10 August 2016 - Elite submitted ANDA for a generic formulation of Percocet - Percocet and its generic equivalents annual sales of approximately $700 million
21 December 2016 - Elite submitted ANDA for aGeneric Hydrocodone, Acetaminophen Combination - combination products of hydrocodone and acetaminophen have total annual US sales of approximately $700 million
4 April 2017 - Elite submitted ANDA for a synthetic narcotic analgesic - annual sales of approximately $40 million

Should see something on generic Percocet soon!

Then there are these that are working for the future -
29 August 2016 Elite Development and License Agreement with SunGen Pharma - Two of the products are classified as CNS stimulants and two of the products are classified as beta blockers. For the twelve months ending June 30, 2016,  the four products and their generic equivalents had total U.S. sales of more than $3 billion.
Elite/SunGen are moving quickly as seen by this progress - 30 May 2017 Elite reported positive topline results from pivotal bioequivalence studies conducted in April of this year for an undisclosed generic product in co-development with SunGen Pharma.  The topline results indicate that the generic product is bioequivalent to the branded product in both fasted and fed studies.

Elite as a company is NOT stopped by this pause for SequestOX!
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent ELTP News